Conflict of Interest Disclosure Index:

A B C D E F G H I J K L M N O P R S T V W Y Z

A

Aburashed, R. A.
Sanofi, Biogen, Teva, Genentech, Novartis, Bayer: Consulting and/or speaker honoraria, and scientific advisory boards
Novartis: Research grants
Alroughani, R.
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Speakers Bureau
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Contracted research
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Speaker honoraria, scientific advisory boards, and research grants
Current Treatment Options in Neurology: Member of the editorial board
Biogen and Novartis: Research grants
Bayer, Biogen, Merck Serono, Novartis, Roche, and Sanofi: Speakers Bureau
Andrews, E. B.
Elizabeth Andrews works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and....: Contracted research
... private organizations including pharmaceutical companies.: Contracted research
Arnold, D. L.
Acorda, Bayer, Biogen, Canadian Institutes of Health Research, Eli Lilly, EMD Serono, genentech, GlaxoSmithKline, MedImmune, Merck Serono, MS Society of canada, NeuroRx Research, Novartis, Opexa Therapeutics, receptos, Roche, Sanofi, and Teva: Compensation for serving as a speaker, consultant, and advisory board participant, and receiving research support
Acorda, Biogen Idec, F. Hoffmann-La Roche, Genentech, Genzyme, Novartis and Sanofi-Aventis: Consulting Fee and Contracted research
NeuroRx Research: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Acorda, Biogen, MedImmune, Mitsubishi Pharma, Novartis, Receptos, Roche, and Sanofi: Consulting Fee
Biogen and Novartis: Grant support
Ayyoub, Z.
Ipsen: Contracted research

B

Bader-Weder, S.
Shareholder of F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche Ltd: Employee of and Salary
F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Bailey, R.
BIOGEN: Speakers Bureau
Balabanov, R.
Grant/research support from Biogen: Contracted research
Biogen, Sanofi, and Teva: Consulting Fee
Balcer, L. J.
Biogen: Consulting Fee
Biogen, Genzyme: Consulting Fee
Banwell, B.
Biogen Idec, Merck Serono, Novartis and Teva Neuroscience: Consulting Fee and Contracted research
Bar-Or, A.
Amplimmune, Bayhill Therapeutics, Berlex/Bayer, Biogen Idec, DioGenix, Eli Lilly, Genentech, Genzyme, GlaxoSmithKline, Guthy-Jackson/GGF, Merck/EMD Serono, Medimmune, Mitsubishi Pharma, Novartis, Ono Pharma, Receptos, Roche, Sanofi, Teva Neuroscience: Consulting Fee and Contracted research
Wyeth: Consulting Fee and Contracted research
Bar-Or, A.
Biogen, Celgene/Receptos, EMD Serono, Genzyme, Medimmune, Novartis, and Roche: Consulting Fee
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Speakers Bureau
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Contracted research
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Consulting Fee
Baranzini, S.
EMD Serono: Consulting Fee
Teva: Consulting Fee
Bardsley, B.
Sanofi-Genzyme: Consulting Fee , Speakers Bureau and Travel to meeting
Biogen: Consulting Fee and Speakers Bureau
Roche: Consulting Fee and Travel to meeting
Merck: Consulting Fee
Barkhof, F.
Biogen-Idec, TEVA, Merck-Serono, Novartis, Roche, Jansen Research, Genzyme-Sanofi, IXICO Ltd, GeNeuro and Apitope Ltd.: Consulting Fee
Barnett, M.
Biogen, Novartis, and Sanofi: Institutional support for research, speaking, and/or participation in advisory boards
Medical Safety Systems: Research consultant
Bartfeld, E.
Irody, Inc.: Employed by the company who provided the technology platform for this study.
Bashir, K.
Research with NIH, NMSS, Novartis, MedImmune, Actelion, Chugai, EMD Serono, Biogenidec: Contracted research
Bass, A. D.
Biogen, Mallinckrodt, Novartis, Roche-Genentech, Sanofi, and Teva Neuroscience: Consulting fees/fees for non-CME services from commercial interest or their agents/grant and research support
Becker, P. M.
Mallinckrodt ARD Inc: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Belachew, S.
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Roche: Salary
Ben-Zacharia, A.
Bayer, Biogen, Genzyme, Genentech: Consulting Fee and Contracted research
Novartis and Biogen: Contracted research
Ben-Zacharia, A.
Biogen, EMD Serono, Novartis Pharmaceuticals, Genentech, Genzyme Corporation, Teva Pharmaceuticals: Consultant
Biogen, Novartis Pharmaceuticals: Grant support
Benamor, M.
Employee of Sanofi: Salary
Benedict, R. H.
Biogen: Consulting Fee and Research Support
Genzyme: Consulting Fee , Contracted research and Research Support
Mallinkrodt: Research support
Abbvie: Consulting Fee
Genentech, Inc.: Consulting Fee
Roche: Consulting Fee
Teva: Consulting Fee
Novartis: Consulting Fee
EMD Serono: CME
Psychological Assessment Resources, Inc.: Royalty
Berger, J.
Amgen, Astra-Zeneca, Janssen, Millennium/Takeda, Novartis, Biogen, Roche, Genentech, Genzyme/Sanofi, Inhibikase, Forward Pharma, Johnson and Johnson, Pfizer, and Eisai: Fees for non-CME services received directly from a commercial interest or its agent and Grants from Biogen
Berkovich, R.
Acorda, Avanair, Bayer, Biogen, Novartis, Questor, Sanofi, and Teva: Advisory Boards
Acorda, Avanair, Bayer, Biogen, Novartis, Questor, Sanofi, and Teva: Consulting Fee
Acorda, Avanir, Bayer, Biogen, Novartis, Questcor, Sanofi, and Teva: Advisory boards and consulting
Berkovich, R.
Bayer AG: Consulting Fee
Biogen: Consulting Fee and Speakers Bureau
Mallinckrodt Pharmaceuticals: Consulting Fee
Novartis AG: Consulting Fee and Speakers Bureau
Sanofi Genzyme: Consulting Fee and Speakers Bureau
Teva Pharmaceutical Industries Ltd: Consulting Fee and Speakers Bureau
Acorda Therapeutics: Consulting Fee and Speakers Bureau
Avanir Pharmaceuticals, Inc: Consulting Fee and Speakers Bureau
Bethoux, F.
Atlas5D: Contracted research
Biogen: Contracted research and Royalty
Ipsen: Consulting Fee
Boster, A.
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Consulting Fee
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Fees for non-CME services received directly from a commercial interest or its agent
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
Biogen, Novartis, Sanofi Genzyme, Genentech, TEVA, and Medtronic: Consulting Fee
Biogen, TEVA, Novartis, Genentech and Roche: Contracted research
Bove, R.
Sanofi-Genzyme, Roche-Genentech and Novartis: Consulting Fee
Bowen, J. D.
Acorda Therapeutics: Consulting Fee , Contracted research and Speakers Bureau
Biogen IDEC: Consulting Fee , Contracted research and Speakers Bureau
Alexion: Contracted research
Alkermes: Contracted research
Allergan: Contracted research
Amgen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech: Consulting Fee , Contracted research and Speakers Bureau
Genzyme: Consulting Fee and Contracted research
Novartis Pharmaceuticals Corporation: Consulting Fee , Contracted research and Speakers Bureau
GlaxoSmithKline: Contracted research
Roche: Contracted research
Sanofi-Aventis: Contracted research
Teva Neuroscience: Consulting Fee and Speakers Bureau
Broadley, S.
Bayer-Schering, Biogen, Merck Serono, Novartis, and Sanofi: Honoraria for participation in advisory boards
Bayer-Schering, Biogen, Merck Serono, Novartis, and Sanofi: Conference travel sponsorship
Biogen and Genzyme: Speaker honoraria
Biogen: Unencumbered research grant
Brochet, B.
Novartis, Biogen: Consulting Fee
Bayer, Merck, Genzyme, Biogen, Novartis, Roche, Actelion, Medday, Teva: Contracted research
Bromley, S. M.
Biogen, Novartis, Sanofi: Research support
Novartis, Sanofi, Biogen, Acorda, Avanir, Teva, and UCB: Consulting and/or speaker honoraria
Brown, M.
The authorís employer (RTI Health Solutions) performs work for multiple pharma and biotech companies, including the study sponsor, on a contract basis; however the author does not receive any of those funds directly nor is his/her salary contingent upon t: Contracted research
Brown, T.
Ipsen: Consulting Fee
Biogen: Consulting Fee
Teva: Consulting Fee
Sanofi-Genzyme: Consulting Fee
Merck: Contracted research
Astellas: Contracted research
Biogen: Contracted research
Brown, T. R.
Biogen Idec: Consulting Fee and Contracted research
Sanofi-Genzyme: Consulting Fee
Teva Neuroscience: Consulting Fee
Ibsen pharaceutical: Consulting Fee
Astellas: Contracted research
Merck: Contracted research
Brueck, W.
Bayer Vital, Biogen, Genzyme, Merck Serono, Novartis, Sanofi-Aventis and Teva Pharma: Consulting Fee and Contracted research
Buffels, R.
F. Hoffmann-La Roche Ltd: Employee of
Bumstead, B.
Biogen, Genentech , Genzyme and Teva: Speaker fees
Burtchell, J.
Novartis: Jeri Burtchell, as an employee of HealthiVibe, LLC, has worked on projects with many pharmaceutical companies.
CureClick and MS SoftServe, Inc.: Patient advisory boards

C

Calabresi, P. A.
PAC has received consulting fees from Disarm Therapeutics, and is PI on research grants to JHU from Annexon, MedImmune, Sanofi, Biogen and Novartis. Peter: Consulting Fee
Dr. Calabresi has received grant support paid to his institution from Annexon, Biogen, MedImmune, Novartis, Sanofi Genzyme, and Teva, and consulting fees from Biogen and DiSARM Therapeutics: Consulting Fee and Contracted research
Campagnolo, D.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Campbell, N.
Employee of and own stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Carattini, T.
Sanofi: Employee
Sanofi: Holder of stock
Carruthers, R.
Roche: Consulting Fee
EMD Serono: Consulting Fee
Sanofi: Consulting Fee
Biogen: Consulting Fee
Novartis: Consulting Fee
Teva: Consulting Fee
Chambers, C.
Research support unrelated to this study (AAAAI/VAMPS, AbbVie Laboratories, Amgen Inc., Bristol-Myers/Squibb, Celgene, Genzyme Sanofi-Aventis, GlaxoSmithKline, Hoffman-La Roche-Genentech, Janssen Pharmaceuticals, Pfizer, Inc., Seqirus, Takeda, UCB USA): Contracted research
Birth Defects Research Part A: Clinical and Molecular Teratology: Compensation for serving as Editor, Associate Editor, or member of an editorial advisory board
Chang, I.
Employee of and own stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Chang, K.
Foundation of the Consortium of Multiple Sclerosis Centersí MS Workforce of the Future program as well as the MS Connect Program: Grant
Chavin, J.
Employee of Sanofi: Salary
Chinea, A.
TEVA, Novartis, Genzyme and Sanofy, Biogen, Acorda, Mallinckrodt: Consulting Fee and Contracted research
Chirieac, M.
Sanofi: Employee
Chitnis, T.
Biogen, F. Hoffmann-La Roche, Merck Serono and Novartis: Consulting Fee and Contracted research
Chitnis, T.
Bayer, Novartis, and Roche-Genentech: Consulting Fee
EMD Serono, Octave, and Verily Life Sciences: Contracted research
Novartis, Sanofi-Genzyme, and Roche-Genentech: Serves on clinical trials advisory board for
Chognot, C.
F. Hoffmann-La Roche Ltd: Employee of
Chung, L.
Sanofi: Employee
CINC, E.
Teva: Speakers Bureau
Clayton, D.
Employee of Genentech Inc: Salary
Cohan, S.
Biogen: Consulting Fee , Contracted research and Speakers Bureau
Sanofi-Genzyme: Consulting Fee , Contracted research and Speakers Bureau
Novartis: Consulting Fee , Contracted research and Speakers Bureau
Roche-Genentech: Consulting Fee , Contracted research and Speakers Bureau
Mallinkrodt: Contracted research
Acorda: Speakers Bureau
Cohen, J. A.
Genentech, Merck, Novartis, and Receptos: Consulting Fee and Contracted research
Adamas and Celgene: Consulting Fee
Multiple Sclerosis Journal Ė Experimental, Translational and Clinical: Co-editor
Comi, G.
Actelion, Bayer, Merck Serono, Novartis, Sanofi, and Teva: Consulting Fee
Bayer, Biogen Dompe, Merck Serono, Novartis, Sanofi, Serono Symposia International Foundation, and Teva: Lecture Fees
Comi, G.
Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Merck, Biogen DompŤ, Bayer Schering, and Serono Symposia International Foundation: Lecture fees
Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Receptos, Biogen Idec, Genentech-Roche, Merck, Biogen DompŤ, and Bayer Schering: Trial grant support
Novartis, Teva Pharmaceutical Industries Ltd., Sanofi-Aventis, Merck, Receptos, Biogen Idec, Genentech-Roche, and Bayer Schering: Consulting Fee
Almirall, Biogen, Celgene/Receptos, EXCEMED, Forward Pharm, Genzyme, Merck, Novartis, Roche, Sanofi, and Teva: Consulting Fee and Speaking activities
Almirall, Biogen, Celgene, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva: Consulting Fee
Almirall, Bayer, Biogen, Excemed, Genzyme, Merck Serono, Novartis, Receptos, Sanofi, SSIF, Teva: Contracted research
Almirall, Biogen, Celgene, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva: Speakers Bureau
Conway, J. M.
biogen, celgene, genentech, genzyme, novartis, teva,: Consulting Fee , Contracted research and Speakers Bureau
Cook, S.
Bayer HealthCare, Merck, Actinobac Biomed, Teva Pharmaceuticals, and Biogen Idec: Advisory boards
Merck, Bayer HealthCare, Sanofi-Aventis, Neurology Reviews, Biogen Idec, Teva Pharmaceuticals, and Actinobac Biomed Inc: Consulting Fee and Honoraria for lectures
Bayer HealthCare: Grant support
Coyle, P. K.
Accordant: Consulting Fee
Acorda: Consulting Fee
Bayer: Consulting Fee
Biogen: Consulting Fee
Celgene: Consulting Fee
EMD Serono: Consulting Fee
Genentech/Roche: Consulting Fee and Contracted research
Novartis: Consulting Fee and Contracted research
Sanofi Genzyme: Consulting Fee
Teva: Consulting Fee
Actelion: Contracted research
Alkermes: Contracted research
MedDay: Contracted research
National Institute of Neurological Disorders and Stroke (NINDS): Contracted research
Consulting fees (AbbVie, Accordant, Acorda, Bayer, Biogen Idec, Celgene, Genentech/Roche, Genzyme/Sanofi, Novartis, Serono, Teva): Consulting Fee
Research support (Actelion, Alkermes, Genentech/Roche, MedDay, NINDS, Novartis, Opexa).: Contracted research
Crabtree-Hartman, E.
Genzyme: Speakers Bureau
Teva: Speakers Bureau
Biogen: Speakers Bureau
Novartis: advisory
Teva: advisory
Biogen: advisory
Cree, B. A.
AbbVie, Biogen, EMD Serono, GeNeuro, Novartis and Sanofi Genzyme: Consulting Fee
MedDay: research support
Abbvie, Biogen, EMD Serono, Genzyme, Novartis, and Shire: Consulting Fee
Biogen: Consulting Fee
EMD Serono: Consulting Fee
Teva: Consulting Fee
Cross, A.
Genentech/Roche: Consulting Fee and Development of Educational Materials; Honoraria
AbbVie: Honoraria
Bayer: Honoraria
EMD Serono: Honoraria
Genzyme: Honoraria
Novartis: Honoraria
Teva: Honoraria
Cutter, G.
AMO Pharmaceuticals, Apotek, BioLineRx, Horizon Pharmaceuticals, Modigenetech/Prolor, Merck, Merck/Pfizer, Opko Biologics, Neurim, Sanofi, Reata Pharmaceuticals, Receptos/Celgene, Teva, NHLBI [Protocol Review Committee], NICHD [OPRU oversight committee]: Data and safety monitoring boards
Atara Biotherapeutics, Argenix, Genzyme, Genentech, GW Pharma, Klein-Buendel Incorporated, MedImmune, Medday, Novartis, Opexa Therapeutics, Roche, Savara Inc., Somahlution, Teva, Transparency Life Sciences, TG Therapeutics: Consulting or advisory boards
Cutter, G.
Medday: Consulting or Advisory Boards
Klein-Buendel Incorporated: Consulting or Advisory Boards
Innate Therapeutics: Consulting or Advisory Boards
Genentech: Consulting or Advisory Boards
Genzyme: Consulting or Advisory Boards
Consortium of MS Centers: Consulting or Advisory Boards
Bioeq GmBH: Consulting or Advisory Boards
Argenix: Consulting or Advisory Boards
Atara Biotherapeutics: Consulting or Advisory Boards
NICHD: OPRU oversight committee
NHLBI: Protocol Review Committee
Teva Pharmaceuticals: Data and Safety Monitoring Boards
Receptos/Celgene: Data and Safety Monitoring Boards
Reata Pharmaceuticals: Data and Safety Monitoring Boards
Sanofi-Aventis: Data and Safety Monitoring Boards
Neurim: Data and Safety Monitoring Boards
Opko Biologics: Data and Safety Monitoring Boards
Merck/Pfizer: Data and Safety Monitoring Boards
Merck: Data and Safety Monitoring Boards
Modigenetech/Prolor: Data and Safety Monitoring Boards
Horizon Pharmaceuticals: Data and Safety Monitoring Boards
Apotek: Data and Safety Monitoring Boards
AMO Pharmaceuticals: Data and Safety Monitoring Boards
Novartis: Consulting or Advisory Boards
Opera Therapeutics: Consulting or Advisory Boards
Roche: Consulting or Advisory Boards
Savara Inc.: Consulting or Advisory Boards
Somahlution: Consulting or Advisory Boards
Teva pharmaceuticals: Consulting or Advisory Boards
Transparency Life Sciences: Consulting or Advisory Boards
TG Therapeutics: Consulting or Advisory Boards

D

D'Hooghe, M.
Teva Pharma, Biogen, Novartis, Roche, Sanofi-Genzyme, Bayer-Schering, Merck-Serono and Allergan.: consultancy fees, travel and research grants
Daizadeh, N.
Sanofi: Employee
Dangond, F.
EMD Serono, Inc.: Salary
de Seze, J.
Roche: Consulting Fee
de Seze, J.
Roche: Consulting Fee
Devonshire, V.
Merck Serono: Consulting Fee
Sanofi: Consulting Fee
Teva: Consulting Fee
Biogen: Consulting Fee
Novartis: Consulting Fee
Dewitt, L. D.
Teva: Consulting Fee
Biogen: Consulting Fee
Didden, E. M.
F. Hoffmann-La Roche Ltd: Employee of and Salary
Dines, K. C.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Dive, D.
Bayer, Merck Serono, Novartis, Sanofi, and Teva: Institutional honoraria for advisory board participation and travel grants
Dix, A.
Sanofi: Participation in advisory boards
Doern, K.
Acorda Therapeutics: Speakers Bureau
Doniger, G.
Neurotrax Corporation: Salary
Doward, L.
RTI Health Solutions: Salary
RTI-HS: RTI-HS performs work for the sponsor and other pharma companies on a contract basis, but the I do not receive any of those funds nor is my salary contingent upon the results of the work for those pharma entities.
Due, B. R.
MedLogix Communications, LLC/Mallinckrodt ARD Inc: Editorial support was provided by MedLogix Communications, LLC, Itasca, Illinois, under the direction of the authors and was funded by Mallinckrodt ARD Inc.
Mallinckrodt ARD Inc.: Salary

E

Eberhard, L.
Oxford PharmaGenesis: Employee
Edwards, K. R.
Biogen, Sanofi Genzyme, Actelion, Eisai, Eli Lily, Forum Pharmaceuticals, Genentech, Hoffman-LaRoche, Merz Pharmaceuticals, Novartis, Pfizer, Vaccinex: Consulting Fee , Contracted research and Speakers Bureau
Edwards, M. R.
Biogen: Salary
Edwards, N. C.
Health Services Consulting Corporation, which received funding from EMD Serono, Inc. to run the analysis: Employment
Eubanks, J.
TG Therapeutics: employee
Evershed, J.
F. Hoffmann-La Roche: Employee of and Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche Products Ltd: Employee of
Roche Products Ltd: Employee of and Salary
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)

F

Farej, R.
Bayer US LLC.: Salary
Feinstein, A.
Merck Serono: scientific advisory board
Avanir Pharmaceuticals: scientific advisory board
Merck Serono: Speakers Bureau
Teva Pharmaceuticals Industries LTd.: Speakers Bureau
Bayer Schering Pharma: Speakers Bureau
Biogen Idec.: Speakers Bureau
The Clinical Neuropsychiatry of Multiple Sclerosis: Royalty
Fernandez, O.
Hospital Foundation FIMABIS: Contracted research
Allergan, Almirall, Bayer-Schering, Biogen, Merck Serono, Novartis, Sanofi, and Teva: Speaking/Consulting
Revista Espanola de Esclerosis Multiple: Compensation for serving as journal editor, associate editor, or member of editorial advisory board
Fiore, D.
Genentech Inc.: Salary
Fisher, E.
Employee of and holds stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Foley, F. W.
Sanofi Genzyme: Speakers Bureau
Foley, J.
Personal compensation and compensation for consulting activities from Biogen, Genentech, Genzyme, Teva: Consulting Fee
Fox, E. J.
AbbVie, Acorda Therapeutics, Allergan, Bayer, Biogen, Chugai, EMD Serono, Genentech, Novartis, Roche, Sanofi Genzyme, Teva, TG Therapeutics: Consulting Fee and Contracted research
Fox, L.
Biogen-Idec and Genetech: Consulting Fee
Fox, R. J.
Actelion, Biogen, Genentech, Novartis, Teva: Consulting Fee
Actelion, Biogen, Novartis: Advisory committees
Biogen, Novartis: Clinical trial contract and research grant funding
Actelion, Biogen, Genentech, Novartis, and Teva: Consulting Fee
Clinical trial contract and research grant funding from Biogen and Novartis: Contracted research
Advisory board committees for Actelion, Biogen, and Novartis: Speakers Bureau
Grant/research support from Novartis: Contracted research
Advisory board from Biogen and Novartis: Speakers Bureau
Actelion, Biogen, Genentech, Mallinckrodt, MedDay, Novartis, Teva, and XenoPort: Consulting Fee
Freedman, M. S.
Actelion, Bayer, Biogen, Hoffman-LaRoche, Merck Serono, Novartis, Opexa, and Sanofi: Serving on advisory boards, board of directors, or other similar group
Actelion, Bayer, Biogen, Canada Innovation, Chugai, EMD Canada, Hoffman-La Roche, Merck-Serono, Novartis, Sanofi, and Teva: Honoraria or consulting fees
Sanofi: Speakers Bureau
Bayer HealthCare, Biogen Idec, EMD Canada, Novartis, Sanofi, Teva Canada Innovation: Consulting Fee
Bayer HealthCare, Genzyme: Contracted research
Bayer HealthCare, Biogen Idec, Chugai, Merck Serono, Novartis, Opexa Therapeutics, Sanofi, Teva Canada Innovation: Member of company advisory boards/board of directors/other similar group
Frohman, E.
Elliot Frohman has received speaker and consultant fees from Novartis, Genzyme, Acorda.: Consulting Fee
Frohman, T.
Teresa Frohman has received speaker fees from Acorda: Fees for non-CME services received directly from a commercial interest or its agent

G

Gaertner, J.
Bayer Vital, Biogen, Novartis and Teva: Consulting Fee and Contracted research
Galetta, S.
Biogen: Consulting Fee
Garas, M.
Shareholder of F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche Ltd: Employee of and Salary
Gelfand, J. M.
MedDay: research support
Ghezzi, A.
Almirall, Biogen, Genzyme, Merck Serono, Novartis, Sanofi-Aventis and Teva: Consulting Fee and Contracted research
Giovannoni, G.
Biogen Idec, Merck, Novartis, and Ironwood: Research support
Abbvie, Atara Bio, Almirall, Bayer Schering Pharma, Biogen Idec FivePrime, GlaxoSmithKline, GW Pharma, Merck, Pfizer Inc, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd, Sanofi-Genzyme, UCB, Vertex Pharmaceuticals, Ironwood, and Novart: Consulting Fee and Speaker honoraria
AbbVie, Atara Biotherapeutics, Almirall, Biogen, Celgene, GlaxoSmithKline, MedDay Pharmaceuticals, Merck & Co (US), Merck Group (Europe), Novartis, Oxford PharmaGenesis, Roche, Sanofi Genzyme, Synthon, Takeda, Teva Pharmaceutical Industries Ltd., UCB (MS): Consulting Fee
Biogen, Sanofi Genzyme, Takeda (multiple sclerosis): Grant/research support
Giovannoni, G.
AbbVie, Almirall, Atara Biotherapeutics, Biogen, Bayer HealthCare, Canbex, Ironwood, Merck, Merck Serono, Novartis, Roche, Sanofi Genzyme, Synthon, Teva and Vertex.: Consulting Fee and Contracted research
Goldman, M. D.
EMD Serono, ADAMAS, Endece, Teva, Genzyme, Novartis: Consulting Fee
Gonzalez, C.
Verily Life Sciences: Salary
Goodin, D. S.
EMD Serono: Speaking Fee
Teva: Speaking Fee
Goodman, A.
AbbVie, Acorda Therapeutics, Biogen Idec, EMD Serono, Genentech/Roche, Sanofi Genzyme, Novarties, Turdue, Teva Neurosciences: Consulting Fee
Gottesman, M.
Biogen, Teva, Genzyme: Consulting Fee
Graves, D.
acorda, genzyme, novartis, teva: Consulting Fee , Contracted research and Speakers Bureau
Graves, J. S.
Biogen: grant support
Genentech: Grant support
Greenberg, B.
Acorda, Chugai, EMD Serono, Genentech, Medimmune, National Multiple Sclerosis Society, National Institutes of Health, Novartis, Patient-Centered Outcomes Research Institute and The Myositis Association: Consulting Fee and Contracted research
Gudesblatt, M.
Biogen: Contracted research and Speaker Fee
EMD Serono: Contracted research and Speaker Fee
Novartis: Contracted research and Speakef Fee
Sanofi-Genzyme: Contracted research and Speaker Fee
Teva: Contracted research and Speaker Fee
Acorda: Speaker Fee
Amgen: Speaker Fee
Guillaume, D.
Roche, Sanofi-Genzyme, Merck, Novartis, Biogen: Consulting Fee

H

Haartsen, J.
Roche, Biogen, Merck, Oxford PharmaGenesis (multiple sclerosis): Consulting Fee
Roche, Biogen, Merck (multiple sclerosis): Speakers Bureau
Biogen, Merck (multiple sclerosis): Travel assistance
Hall, L.
CMSC grant: Contracted research
Halstead, E. J.
MyHealios: Salary
Genentech: Contracted research
Hardeman, P.
TEVA: Speakers Bureau
Harris, C.
EMD Serono, Hoffmann-La Roche Limited, Sanofi Genzyme, Pendopharm, Biogen Canada, and Novartis Pharmaceuticals: Consulting Fee
Hartung, H. P.
Bayer, Biogen, CSL Behring, Grifols, Merck Serono, Novartis, Roche, and Sanofi: Consulting and/or speaking fees
Bayer, Biogen, Geneuro, Genzyme, Merck, Medimmune, Novartis, Octapharma, Opexa, Roche, Sanofi, and Teva: Consulting Fee , Speakers Bureau and Steering Committee
Hashemi, L.
Sanofi: Employee
Employee of Sanofi: Salary
Hauser, S. L.
Annexon: Scientific Advisory Board
Symbiotix: Scientific Advisory Board
Bionure: Scientific Advisory Board
Molecular Stethoscope: Scientific Advisory Board
Neurona Therapeutics: Board of Trustees
F. Hoffman-La Roche Ltd: travel reimbursement and writing assistance
Options granted for the SAB and BOT activities: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Symbiotix, Annexon, Bionure, and Molecular Stethoscope: Scientific advisory board
F. Hoffman-La Roche Ltd. for CD20-related meetings and presentations.: Travel reimbursement and writing assistance
Havla, J.
Dr. Havla has received consultancy fees from Novartis, Genzyme, Santhera and Merck. He has received reimbursements of congress attendance and travel costs from Novartis, Merck, and Bayer.: Consulting Fee
Havrdova, E. K.
Actelion, Biogen, Celgene, Merck, Novartis, Roche, Sanofi, and Teva: Consulting Fee and Speakers Bureau
Czech Ministry of Education, project PROGRES Q27/LF1: Financial support
Hayward, B.
EMD Serono, Inc., Rockland, MA, USA (a business of Merck KGaA, Darmstadt, Germany): Employment
Head, J.
Consortium of Multiple Sclerosis Centers: Contracted research
Healey, K. M.
Teva, Biogen Idec unbranded only: Speakers Bureau
Healy, B. C.
Biogen Idec: Consulting Fee
Merck Serono, Novartis, Genzyme, Verily Life Sciences: Contracted research
Hedera, P.
Elsevier Publishing: Royalty
Teva: Speakers Bureau
Ipsen: Speakers Bureau
Hellwig, K.
Roche, Novartis, Teva, Bayer, Novartis, Merck, Genzyme, Biogen: Speakers Bureau
Teva, Novartis, Biogen, Genzyme: Contracted research
Roche, Novartis, Teva, Bayer, Novartis, Merck, Genzyme: Consulting Fee
Hemmer, B.
Bernhard Hemmer has served on scientific advisory boards for F. Hoffmann-La Roche Ltd, Novartis, Bayer AG, and Genentech; he has served as DMSC member for AllergyCare and TG Therapeutics; he or his institution have received speaker honoraria from Biogen I: Receipt of Intellectual Property Rights / Patent Holder
Hendin, B.
Biogen, EMD Serono, Teva, Genentech, Novartis: Consulting Fee and Contracted research
Herbert, L. B.
Health Union: Contracted research
Hernandez-Diaz, S.
Pfizer, GSK, Lilly: Contracted research
Boehringer-Ingelheim, UCB: Consulting Fee
Hicking, C.
Merck KGaA: Salary
Hillstrom, H. J.
JAK Tool: Consulting Fee
Moximed: Consulting Fee
Moximed: Contracted research
Ho, P. R.
Employee of and own stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Hobart, J.
Acorda, Asubio, Bayer Schering, Biogen Idec, F. Hoffmann-La Roche, Genzyme, Merck Serono, Novartis, Oxford PharmaGenesis, Teva: Consulting Fee and Honoraria, meeting attendance support or research support
Hotermans, C.
Employee of Biogen: Salary
Houtchens, M. K.
EMD Serono, Inc.: Funding support
Biogen, Genzyme Sanofi, Teva Neuroscience, and Novartis: Advisory board
Genzyme Sanofi: Contracted research and Genzyme Sanofi
Hubeaux, S.
F. Hoffman-La Roche AG Basel: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffman-La Roche AG Basel: Salary
Hunter, S. F.
Actelion, ADAMAS, Bayer Healthcare, Genzyme, Novartis, Acorda, Roche, AbbVie, Synthon, Avanir, Questcor, Osmotica, Biogen Idec, and Teva: Consulting agreements, speaker honoraria, and grant/research financial support
Acorda Therapeutics, Avanir, Bayer HealthCare Pharmaceuticals, Novartis, Osmotica, Roche/Genentech, Sanofi Genzyme and Teva Neuroscience.: consulting fees and/or research support from and/or served on speakersí bureaux

I

Ionete, C.
Biogen Idec: Consulting Fee
Genzyme/Sanofi: Contracted research
Genzyme/Sanofi: Consulting Fee
Bioge. Genentech, Genzyme/Sanofi: Contracted research
Izquierdo, G.
Almirall, bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva: Speaking and advisory fees
Almirall, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva: Speaking and advisory fees

J

Jackson, F.
Teva UK: Consulting Fee
Sanofi Genzyme: Consulting Fee
Merck: travel bursary
Jones, D. E.
Biogen: Consulting Fee and Salary Support for Site Participation in Clinical Trial
Sanofi: Consulting Fee
Genzyme: Consulting Fee
Jordan, B.
Biogen: Salary
Julian, L.
Genentech, Inc.: Salary
F. Hoffmann La-Roche Ltd.: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche: Salary
Jurgensen, S.
Sanofi: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary

K

Kantor, D.
AbbVie, Actelion, Biogen, Celgene, EMD Serono, Mylan, Novartis and Sanofi Genzyme.: Consulting Fee
Kantor, D.
AbbVie, Actelion, Biogen, Celegene, EMD Serono, Mylan, Novartis and Sanofi Genzyme.: Consulting Fee
Actelion: Contracted research
Kantor, D.
Actelion, Sanofi: Research grants
AbbVie, Actelion, Bayer, Biogen, Celgene, EMD Serono, Genentech, Mylan, Novartis, and Sanofi: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
Kappos, L.
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Bayer, Biogen, European Union, Merck, Novartis, Roche, Swiss MS Society, and Swiss National Research Foundation: Grants
Kappos, L.
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Bayer, Biogen, European Union, Merck, Novartis, Roche, Swiss MS Society, and Swiss National Research Foundation: Grants
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Karpatkin, H.
Accorda Therapeutics: Speakers Bureau
Kasliwal, R.
Employee of and own stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Kastrukoff, L.
Biogen: Consulting Fee
EMD Serono: Consulting Fee
Novartis: Consulting Fee
Roche: Consulting Fee
Sanofi: Consulting Fee
Kazimirchik, A.
Hoffmann-La Roche Limited, EMD Serono, Sanofi Genzyme, Novartis Pharmaceuticals Canada Inc.: Consulting Fee
Keller, J.
Genzyme: Contracted research
Kilgo, W. A.
CMSC and NMSS: Fellowship Funding
Kim, H. J.
MS Journal-Experimental, Translational and Clinical and Journal of Clinical Neurology: Co-editor/associated editor
MedImmune: Steering Committee Member
Ministry of Science & ICT, Sanofi, Teva-Handok, and UCB: Research support
Bayer Schering Pharma, Biogen, Eisai, HanAll BioPharma, MedImmune, Merck Serono, Novartis, Sanofi, Teva-Handok, and UCB: Speaking and/or consulting
Kister, I.
Has served on advisory boards of Biogen, Genentech.: Advisory Board
Kister, I.
Biogen, Genentech: Consulting Fee
Guthy-Jackson Charitable Foundation, National Multiple Sclerosis Society, Biogen Idec, Serono, Genzyme, Novartis.: Contracted research
Klein, J.
Teva: Consulting Fee
Biogen: Consulting Fee
Koendgen, H.
F. Hoffmann-La Roche Ltd: Employee of and Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Kolind, S.
Acorda and Genzyme: Consulting Fee
Roche and MS Society of Canada: Contracted research
Kolodny, S.
Novartis Pharmaceuticals Corporation: Salary
Koulinska, I.
Employee of Biogen: Salary
Kresa-Reahl, K.
Biogen and EMD Serono, Inc.: Consulting Fee
Biogen, EMD Serono, Inc., Genzyme, Mallinckrodt, Novartis, and Teva: Honoraria and Speakers Bureau
Biogen, Genentech, Genzyme, Mallinckrodt, and Novartis: Contracted research
Krupp, L.
Avanir, Biogen Idec, Celgene Corporation, Department of Defense, ER Squibb & Sons, Genentech, Johnson & Johnson, Lourie Foundation, Multicell, Osmotica, National Institutes of Health, National Multiple Sclerosis Society, Novartis Pharmaceuticals: Consulting Fee and Contracted research
Slomo and Cindy Silvian Foundation, Teva Neurosciences and the Multiple Sclerosis Foundation: Consulting Fee and Contracted research
Kubala Havrdova, E.
Actelion, Biogen, Merck Serono, Novartis, Celgene, Roche, Sanofi, and Teva and supported by Ministry of Education of Czech Republic (PROGRES Q27/LF1): Honoraria and grant support

L

LaGanke, C.
Acorda Therapeutics, Bayer, Biogen, Cephalon, EMD Serono, Novartis, Pfizer, Questcor, Sanofi, Strativa, Teva, and UCB: Consulting Fee
Langdon, P. D.
Bayer, Novartis, Biogen Idec: Speakers Bureau
Merck Serono, Novartis, Bayer: Consulting Fee
Bayer: Fees for non-CME services received directly from a commercial interest or its agent
LaRose, A.
Bayer Pharaceuticals: Salary
Lazarus, K. J. L.
Novartis: Speakers Bureau
Lee, J. M.
Genzyme, Novartis, Teva and Acorda Therapeutics: Served on advisory board and speakers bureau
Lee, L.
Employee of and holds stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Leocani, L.
L. Leocani received honoraria for consulting services or speaking activities from Roche, Novartis, Merck KGaA, Biogen, and Almirall: Consulting Fee
Levesque, V.
Genentech/Roche: Salary
Levy, M.
NIH/NINDS: Contracted research
Li, C.
F. Hoffmann-La Roche Ltd: Employee of
Li, D.
Canadian Institute of Health Research and MS Society of Canada; is Emeritus Director of the UBC MS/MRI Research Group which was contracted to perform central analysis of MRI scans for therapeutic trials with Novartis, Perceptives, Roche and Sanofi-Aventis: Contracted research
Investigator-initiated independent studies from Genzyme, Merck-Serono, Novartis and Roche: Grant support
Vertex Pharmaceuticals: Consultant
Opexa Therapeutics: Served on Data and Safety Advisory Board
Adelphi Group, Celgene, Novartis and Roche: Served on Scientific Advisory Board
Supported by non-restricted education grants from Teva, Novartis and Biogen: Given lectures
Limmroth, V.
Bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva, with approval by the HR-Department, Cologne General Hospital, and University of Cologne: Honoraria for consulting and speaking at symposia
Livingston, T.
Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Lublin, F.
AbbVie, Acorda, Actelion, Akros, Amgen, Bayer HealthCare Pharmaceuticals, Biogen Idec, EMD Serono, Forward Pharma, MedDay, MedImmune, Novartis, Osmotica, Questcor Mallinckrodt, Receptos, Roche Genentech, Sanofi Genzyme, Teva Neuroscience, TG Therapeutics,: Consulting Fee and Contracted research
Toyama: Advisory Board, DSMB and Consulting Fee
Regeneron: Advisory Board, DSMB and Consulting Fee
Abbvie: Advisory Board, DSMB and Consulting Fee
TG Therapeutics: Advisory Board, DSMB and Consulting Fee
Akros: Advisory Board, DSMB and Consulting Fee
Forward Pharma: Advisory Board, DSMB and Consulting Fee
Receptos/Celgene: Advisory Board, DSMB and Consulting Fee
MedImmune: Advisory Board, DSMB and Consulting Fee
Roche/Genentech: Advisory Board, DSMB and Consulting Fee
Accorda: Advisory Board, DSMB and Consulting Fee
Sanofi/Genzyme: Advisory Board, DSMB and Consulting Fee
Actelion: Advisory Board, DSMB and Consulting Fee
EMD Serono: Advisory Board, DSMB and Consulting Fee
Bayer Healthcare Pharmaceuticals: Advisory Board, DSMB and Consulting Fee
NMSS: Contracted research
NIH: Contracted research
Transparency Life Sciences: Contracted research
Celgene: Contracted research
Sanofi: Contracted research
Genzyme: Contracted research and Speakers Bureau
Teva Neuroscience: Advisory Board, DSMB , Consulting Fee and Contracted research
Novartis Pharmaceuticals Corp: Advisory Board, DSMB , Consulting Fee and Contracted research
Biogen Idec: Advisory Board, DSMB , Consulting Fee and Contracted research
Medday: Advisory Board, DSMB and Consulting Fee
Atara Biotherapeutics: Advisory Board, DSMB and Consulting Fee
Polpharma: Advisory Board, DSMB and Consulting Fee
Mapi Pharma: Advisory Board, DSMB and Consulting Fee
Innate Immunotherapeutics: Advisory Board, DSMB and Consulting Fee
Apitope: Advisory Board, DSMB and Consulting Fee
Genentech (non-promotional): Speakers Bureau
Genzyme (non-promotional): Speakers Bureau
Multiple Sclerosis and Related Disorders: co-chief editor, Multiple Sclerosis and Related Disorders
Lycke, J.
Almirall, Biogen, Novartis, Sanofi, and Teva: Scientific advisory boards
Biogen, Novartis, Sanofi, and Teva: Travel support and/or lecture honoraria
Acta Neurologica Scandinavica: Editorial board
Biogen, Novartis, and Teva: Unconditional research support
Lynch, S. G.
Dr. Lynch has participated in multi-center clinical trials in MS funded by Biogen, Genzyme, Teva, Sanofi, Novartis, Opexa, Roche, NIH, NMSS, Acorda, Sun Pharma, Vaccinex, and Actelion,: clinical trials research
Lysandropoulos, A.
Sanofi: Employee

M

Macdonell, R. A.
Biogen, Merck, Novartis, Sanofi, and Teva: Research support
Bayer, Biogen, Merck, Novartis, Roche, Sanofi, and Teva: Compensation for advisory board and/or speaking fees
Machado, A.
Abbott: Consulting Fee
Enspire: Receipt of Intellectual Property Rights / Patent Holder
Machemer, D.
Genentech, Inc.: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Makh, S.
Employee of and holds stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Mandel, M.
Sanofi: Employee
Manfrini, M.
F. Hoffmann-La Roche Ltd: Employee of
F. Hoffmann-La Roche: Salary
Marcillat, C.
F. Hoffmann-La Roche Ltd: Employee of and Salary
Margulis, A. V.
... organizations including pharmaceutical companies.: Contracted research
A. V. Margulis works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and private: Contracted research
Markowitz, C.
Genentech/Roche, Biogen, Teva, EMD Serono, Bayer, Novartis, Genzyme/Sanofi, and Cellgene: Consulting Fee
Masterman, D.
Genentech Inc., A Member of the Roche Group: Receipt of Intellectual Property Rights / Patent Holder
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech Inc: Salary
Maurer, M.
Bayer-Schering, Biogen, Merck-Serono, Novartis, Roche, Sanofi, and Teva: Research and travel grants, honoraria for MS expert advice and speakerís fees
Mayer, L.
Sanofi Genzyme: Consulting Fee and Honoraria
Novartis: Consulting Fee and Honoraria
Genentech: Consulting Fee and Honoraria
Biogen: Consulting Fee and Honoraria
Mayer, L.
Biogen, EMD Serono, Genentech, Novartis, Sanofi, and Teva: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
McDougall, F.
Roche Products Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche Products Ltd: Salary
Mealy, M. A.
NIH: Grant Number TL1 TR001078 FROM NCATS AND NIH Roadmap for Medical Research
Meier-Davis, S.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Fibrogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Melanson, M.
Sanofi: Employee
Meng, X.
Novartis Pharmaceuticals Corporation: Salary
Merschhemke, M.
Novartis: Salary
Metzger, R.
Personal compensation from Biogen for advisory board activities: Advisory Board
Spouse holds stock in Biogenspouse holds stock in Biogen and is employed by Sanofi: Spouse disclosures
Milahova, T.
teva UK: teaching fee
Merck: Consulting Fee
Miller, A. E.
Accordant Health Services, Acorda Therapeutics, Alkermes, Biogen Idec, EMD Serono, Genentech/Roche, Genzyme, GSK, Mallinckrodt Pharmaceuticals [Questcor], Novartis, Roche, Teva: Consulting Fee
Biogen Idec, Genentech, Novartis, Questcor, Roche, Sanofi: Fees for non-CME services received directly from a commercial interest or its agent
Miller, C.
Sanofi: Employee
Miller, D.
Hoffmann-La Roche Ltd: Consulting Fee
National Multiple Sclerosis Society: Contracted research
Milner, I.
Bayer: MSNA (Award prize)
Minton, N.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Miravalle, A.
Genentech: Consulting Fee and Grant Funding
Mitchell, C. P.
Sanofi: Employee
Mitchell, E.
Genentech: Consulting Fee
Teva: Speakers Bureau
Genzyme: Speakers Bureau
Model, F.
Roche: Salary
Mok, K.
TG Therapeutics: employee
Mokliatchouk, O.
Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Biogen: Salary
Montalban, X.
Almirall, Bayer, Biogen, Genzyme, Merck, Novartis, Oryzon,Receptos, Roche, Sanofi-Genzyme, Teva: Consulting Fee
Montalban, X.
Almirall, Bayer, Biogen, Genzyme, Merck, Novartis, Oryzon,Receptos, Roche, Sanofi-Genzyme, Teva: Consulting Fee
Montalban, X.
Almirall, Bayer Schering Pharma, Biogen, Genentech, Genzyme, GSK, Merck Serono, MS International Federation, National Multiple Sclerosis Society, Novartis, Roche, Sanofi-Aventis, and Teva: Speaking honoraria and travel expenses for scientific meetings or has participated in steering committees or in advisory boards for clinical trials
MSJ: Editor for clinical cases
Montero-Embalsado, C.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Moore, M.
biogen, celgene, genzyme: Consulting Fee and Speakers Bureau
Morrow, S. A.
Biogen Idec, EMD Serono, Genzyme, Novartis, and Roche: Advisory Board , Consulting Fee and Speakers Bureau
Novartis, Genzyme and Roche: site principal investigator for clinical trials
Genzyme: investigator initiated trial funding
Mowry, E. M.
Biogen, Genzyme- investigator-initiated studies Site PI of studies sponsored by Biogen, Sun Pharma Teva provides free med for a clinical trial of which I am PI Royalties from UpToDate for editorial duties: Contracted research and Royalty
Mueser, K. T.
MyHealios: Consulting Fee
Munoz, K.
Sanofi: Employee
Muser, R.
Acorda Therapeutics, Inc: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary

N

Naismith, R. T.
Alkermes, Biogen, EMD Serono, Genzyme, Novartis, Teva: Consulting Fee
Acorda, Genentech: Speakers Bureau
Nakamura, K.
Biogen and Sanofi: Speaking fees and research support
Biogen: Royalty fees for licenses
Namey, M.
Biogen, Genentech, Sanofi-Genzyme, Acorda Therapeutics, Avanir, EMD Serono, Novartis, Teva Neuroscience: Consulting Fee and Speakers Bureau
Napieralski, J.
F. Hoffmann-La Roche Ltd: Employee of
Napoli, S.
Questcor Pharmaceuticals: Consulting Fee
Teva Neuroscience: Consulting Fee
Biogen: Consulting Fee
Pfizer: Consulting Fee
Accorda: Consulting Fee
Serono: Consulting Fee
Novartis: Consulting Fee
Genzyme Pharmaceuticals: Consulting Fee
Naylor, M. L.
Employee and stockholder of Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Nedelcu, S.
CMSC grant: CMSC Grant
Nelson, J. R.
Hoffmann-La Roche Limited, Teva Canada Innovation, EMD Serono, Sanofi Genzyme, Biogen Canada: Consulting Fee
Newsome, S. D.
Biogen, Genentech, Novartis, Celgene, Serono, Syntimmune: Consulting Fee and Contracted research
Nicholas, J. A.
Biogen Idec: Advisory committe , Consulting Fee and Speakers Bureau
Novartis: Advisory committe , Consulting Fee and Speakers Bureau
Sanofi Genzyme: Advisory committe , Consulting Fee and Speakers Bureau
Genentch: Advisory committe , Consulting Fee and Speakers Bureau

O

Ontaneda, D.
Genzyme: Consulting Fee
Merck: Consulting Fee
Genzyme: Contracted research
Novartis: Contracted research
Genentech: Contracted research
Opiteck, G. J.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Oreja-Guevara, C.
Alexion, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva: Speaker honoraria and compensation for consulting services

P

Pace, A.
Teva UK: teaching fee
Sanofi Genzyme: Consulting Fee
Merck: Consulting Fee
Parizel, P.
Icometrix: Board member
Patel, M.
Biogen: Salary
Paul, F.
F. Paul serves on the scientific advisory board for Novartis; received speaker honoraria and travel funding from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis/Genzyme, Merck Serono, Alexion, Chugai, MedImmune, and Shire; is an academic editor for PLo: Consulting Fee
Paz Soldan, M. M.
Biogen: Research support
Pearce, G. L.
Novartis: Salary
Pelletier, D.
Biogen, Merck Serono, Novartis, Roche, and Sanofi: Consulting and/or speaking fees and grant/research support
Pepper, G.
Biogen, Novartis, Oxford PharmaGenesis, Teva (multiple sclerosis): Consulting Fee
Perumal, J.
Acorda, Biogen, Genzyme, and Teva: Consulting Fee
Peskin, A. E.
Acorda Therapeutics: Speakers Bureau
Phillips, A. L.
EMD Serono, Inc., Rockland, MA, USA (a business of Merck KGaA, Darmstadt, Germany): Employment
Piani Meier, D.
Novartis Pharmaceuticals Corporation: Salary
Picaut, P.
Ipsen: Employment
Pilutti, L. A.
National Multiple Sclerosis Society: Funding
Poole, E.
Employee of Sanofi: Salary
Pozzilli, C.
Actelion, Biogen, Merck, Novartis, Sanofi, and Teva: Consulting and/or speaking fees, research, and travel grants
Biogen, Genzyme, Roche, Merck-Serono, Novartis, Sanofi and Teva: Consulting Fee
Pradhan, A.
Genentech, Inc.: Salary
Roche and Genentech: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Prins, B.
managing partner of ITAM: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Putzki, N.
Novartis Pharmaceuticals Corporation: Salary

R

Racke, M. K.
Coherus: Consulting Fee
Eisai: Consulting Fee
Cipla: Consulting Fee
Genentech: Contracted research
Actelion: Contracted research
Novartis: Contracted research
Immune Tolerance Network: Contracted research
Alkermes: Contracted research
Journal of Neuroimmunology: Honoraria as Editor in Chief
Raghupathi, K.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Rametta, M.
Bayer HealthCare: Employee of Bayer HealthCare
Rammohan, K.
EMD Serono, Biogen Idec, Sanofi-Aventis, Genzyme, Novartis, Teva Neurosciences, Acorda, and Roche/Genentech: received honoraria for lectures and steering committee meetings
Genentech: Consulting Fee and Grant Support & Honoraria
Genzyme: Consulting Fee and Honoraria
Novartis: Consulting Fee and Grant Support & Honoraria
EMD Serono: Consulting Fee and Honoraria
Biogen: Consulting Fee and Grant Support & Honoraria
Teva: Honoraria
Ren, Z.
Employee of and own stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Rensel, M. R.
Biogen: Consulting Fee and Speakers Bureau
Genzyme: Contracted research and Speakers Bureau
Teva: Speakers Bureau
Novartis: Speakers Bureau
NMSS: Contracted research
Repovic, P.
Biogen, Genzyme, Teva, Genentech, and EMD Serono.: Consulting Fee
Riddle, E.
Employee of and own stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Rieckmann, P.
Merck, Biogen Idec, Bayer Schering Pharma, Boehringer-Ingelheim, Sanofi-Aventis, Genzyme, Novartis, Teva Pharmaceutical Industries, and Serono Symposia International Foundation: Honoraria for lectures/steering committee meetings
Rieckmann, P.
Almirall, Apple Healthcare, Baxter, Bayer, Biogen Idec, Boehringer-Ingelheim, Cerner, Daiichi Sankyo, Genpharm, Genzyme, Medtronic, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Siemens AG and Teva: Speakers Bureau
Bayer, EMD Serono, Novartis, Teva, MS Society of Canada, Canadian Institute of Health Research, Hertie Foundation, Oberfranken-Stiftung and German Neurology Foundation: Contracted research
Abbvie, Bayer, Biogen Idec, Novartis, Merck KGaA, Teva, German Multiple Sclerosis Society and Canada Drug Review: Consulting Fee
Ritter, S.
Novartis Pharmaceuticals Corporation: Salary
Rivero-Ferrer, E.
... private organizations including pharmaceutical companies. RTI Health Solutions received contract funding from Roche, with retention of independent publication.: Contracted research
Elena Rivero-Ferrer works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and...: Contracted research
Roberts, C. M.
Greenwich Biosciences and Insys Therapeutics: Contracted research and non-cme education for LivaNova
Roberts, H.
Acorda Therapeutics, Inc: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Rog, D.
Mecrk: Consulting Fee
Roche: Consulting Fee
Sanofi Genzyme: Consulting Fee
Teva UK: Consulting Fee
Biogen: Consulting Fee
Rosado-Baron, N.
Acorda Therapeutics, Inc: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Rose, J. W.
Biogen: Recieved research support
Teva: Received research support
Guthy Jackson Charitable Foundation: Research Support
National MS Society: Research Support
Rostasy, K.
Novartis: Consulting Fee and Contracted research
Rovira, A.
Bayer, Biogen, Bracco, Novartis, Sanofi, and Stendhal: Consulting and/or speaking fees
Rus, H.
Teva Neuroscience: Grant
Russo, M.
Acorda Therapeutics, Inc: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary

S

Salvetti, M.
Received grant support and speaker honoraria from Biogen: Contracted research and Speakers Bureau
Sammarco, C.
Biogen, Genentech and Genzyme: Consultant
Santra, S.
Employee of and holds stock and/or stock options in Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Sayao, A. L.
Teva: Consulting Fee
Biogen: Consulting Fee
Roche: Consulting Fee
Serono: Consulting Fee
Sanofi: Consulting Fee
Novartis: Consulting Fee
Schippling, S.
Biogen, Merck Serono, Novartis, Sanofi, and Teva: Consulting and/or speaking fees and grant/research support
Schofield, L.
Novartis Pharmaceuticals Corporation: Salary
Schreiner, T.
Biogen: Contracted research
Scott, F. L.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Seeldrayers, P.
Biogen, Bayer Schering, Genzyme, Merck, Teva, Sanofi and Roche: travel grants and honoraria for lectures and consulting
Selmaj, K. W.
Biogen, Genzyme, Merck, Novartis, Ono Pharma, Receptos, Roche, Synthon, and Teva: Consulting Fee
Selmaj, K. W.
Biogen, Merck, Novartis, Roche, Sanofi, and Synthon: Consulting and/or speaking fees
Sharaf, N.
teva UK: Teaching fee
Sharrock, K.
Sanofi: Employee
Sheffield, J. K.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Shirley, J.
Sanofi: Employee
Siengsukon, C.
Owner of Sleep Health Education, LLC: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Silva, D.
Novartis Pharmaceuticals Corporation: Salary
Simnad, V. I.
Biogen: Contracted research
Novartis: Contracted research
Singer, B. A.
Acorda, Alkermes, Biogen, MedImmune, Novartis, Roche, Sanofi: Research support
Acorda, Bayer, Biogen, EMD Serono, Genentech, Pfizer, Novartis, Sanofi, and Teva: Speaking and/or consulting
Sloane, J. A.
Biogen, Celgene, Genentech, Sanofi Genzyme, Teva: Consulting Fee , Contracted research and Speakers Bureau
Slota, C.
The authorís employer (RTI Health Solutions) performs work for multiple pharma and biotech companies, including the study sponsor, on a contract basis; however the author does not receive any of those funds directly nor is his/her salary contingent upon t: Contracted research
Smith, A.
Sanofi: Employee
Employee of Sanofi: Salary
Smith, T. J.
GEOMC, Inc: Travel expenses from the manufacturers of Scrambler Therapy machines, to teach at the 5th Annual Conference on Scrambler Therapy
Smoot, K. E.
Acorda, Biogen, Genentech, Genzyme, Novartis, and Teva: Consulting Fee
Biogen and Genentech: Contracted research
Acorda, Biogen, Genentech, Genzyme, Novartis, and Teva: Speakers Bureau
Soelberg Soerensen, P.
Merck, Teva, GSK, and Novartis; has received speaker honoraria from Biogen Idec, Merck, Teva, Sanofi-Aventis, Genzyme, and Novartis: steering committees or independent data monitoring boards in trials sponsored by
Biogen, Merck, Teva, Novartis, Roche, and Genzyme: Department received research support
Biogen, Merck, Novartis, Teva, MedDay Pharmaceuticals, and GSK: Advisory boards
Sprenger, T.
Actelion, Novartis, Sanofi Genzyme, Electrocore, Merck and TEVA.: Consulting Fee
Steinman, L.
Abbvie, Atreca, Celgene/Receptos, Novartis, Teva, Tolerion, and EMD Serono: Consulting Fee
Atara, Biogen, and Celgene: Contracted research
Stites, T.
Novartis: Salary
Stokmaier, D.
F. Hoffmann-La Roche Ltd: Employee of and Salary
Su, W.
TG Therapeutics: employee
Suarez, G.
Ipsen: Employment
Sullivan, A. B.
Novartis: Consulting Fee and Speakers Bureau
Sullivan, C.
Sanofi Genzyme: Consulting Fee , Contracted research and Speakers Bureau

T

Talbot, P.
Teva UK: teaching fee
Tardieu, M.
Novartis, Sanofi and UniQure: Consulting Fee and Contracted research
Taylor Meadows, K. R.
Celgene: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Tenenbaum, N.
Novartis Pharmaceuticals Corporation: Salary
Teter, B. E.
Biogen Idec, Teva Neurosciences, EMD Serono, Avanir, Genzyme and Novartis: Contracted research
Thangavelu, K.
Sanofi: Employee
Sanofi: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary
Thomas, F. P.
Acorda Therapeutics, Genzyme and Teva Neuroscience: Consulting Fee
Tomic, D.
Novartis Pharmaceuticals Corporation: Salary
Tornatore, C.
Biogen, Genzyme, and Novartis: Consulting Fee
Biogen: Speakers Bureau
Traboulsee, A.
Biogen, Chugai, Roche, Sanofi, and Teva: Consulting and/or speaking fees
Biogen, Chugai, Roche, Sanofi, and Teva: Grant/research support
Roche: Contracted research
Genzyme: Contracted research
Roche: Consulting Fee
Teva: Consulting Fee
Canada Innovation: Consulting Fee
Mercke/EMD: Consulting Fee
EMD: Consulting Fee
Sanofi: Consulting Fee
Sanofi Genzyme, Teva Neuroscience: Speakers Bureau
Sanofi Genzyme, Roche, Chugai, Novartis, Biogen: Contracted research
Sanofi Genzyme, Roche, Teva Neuroscience, Novartis, Biogen, EMD Serono: Consulting Fee
Biogen, Roche, EMD Serono and Teva Pharmaceuticals: Consulting Fee
Biogen, Chugai, CIHR, Roche, Michael Smith Foundation and the MS Society of Canada: Contracted research
Truffinet, P.
Sanofi: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary

V

Van Hecke, W.
CEO of Icometrix: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Van Pesch, V.
Biogen, Bayer Schering, Genzyme, Merck, Teva, Sanofi and Roche: travel grants
Biogen, Bayer Schering, Sanofi, Merck, Roche, Teva and Novartis Pharma: Consulting Fee
Novartis Pharma, Bayer Schering, Sanofi and Roche: Contracted research
Van Wijmeersch, B.
Bayer-Schering, Biogen, Merck-Serono, Novartis, Roche, Sanofi, and Teva: Research and travel grants, honoraria for MS expert advice and speakerís fees
Verdun di Cantogno, E.
Merck KGaA: Salary
Vermersch, P.
Almirall, Bayer, Biogen, Celgene, Merck Serono, Novartis, Sanofi, Servier, and Teva: Consulting fees and/or speaking fees, and research support
Vernon, K.
Sanofi Genzyme: Consulting Fee
Teva UK: Consulting Fee
Roche: Consulting Fee
Merck: Consulting Fee
Biogen: Consulting Fee
Villoslada, P.
Dr. Pablo Villoslada hold stocks in Bionure Inc, Spire Bioventures, Mint-Labs and Health Engineering and is an employee of Genentech Inc at present.: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Villoslada, P.
Employee of Genentech: Salary
Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
von Geldern, G.
Novartis: Contracted research
Vorobeychik, G.
Hoffmann-La Roche Limited, Teva Canada Innovation, EMD Serono, Sanofi Genzyme, Biogen Canada, Novartis Pharmaceuticals Canada Inc.: Consulting Fee and Unrestricted educational grant from EMD Serono, Hoffmann-La Roche Limited
Vukusic, S.
Bayer-Schering, Biogen Idec, F. Hoffmann-La Roche Ltd, Genzyme, Novartis, Merck Serono, Sanofi Aventis and Teva Pharma: Consulting Fee and Lecture fees, Travel Grants, Researc Support

W

Wakeford, C.
Employee and stockholder of Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
Walker, B.
Sanofi, EMD Serono and Biogen: Participation in advisory boards
Wang, Q.
F. Hoffmann-La Roche Ltd: Employee of and Salary
Waubant, E.
National Institutes of Health, National Multiple Sclerosis Society, Novartis, Race to Erase MS and Roche: Consulting Fee and Contracted research
Weinstock-Guttman, B.
Biogen Idec, Teva Neuroscience, EMD Serono, Novartis, Questcor, Sanofi Genzyme, Aspreva,: Consulting Fee , Contracted research and Speakers Bureau
Weiss, M.
TG Therapeutics: Employee
Wiendl, H.
Huber-Verlag: License fee payments
Neotope Bioscience, Novartis, and PML Consortium: Grant/research support
Bayer, Biogen, Behring, EMD Serono, Fresnius Medical Care, Merck Serono, Novartis, Sanofi, Roche, and Teva: Consulting and/or speaking fees
Bayer, Biogen, Behring, EMD Serono, Fresenius Medical Care, Merck Serono, Novartis, Sanofi, Roche, and Tevae: Consulting and/or speaking fees
Willekens, B.
Roche, Sanofi-Genzyme, Merck, Novartis, Biogen: Consulting Fee
Novartis, Roche: Contracted research
Teva, Roche, Sanofi-Genzyme, Merck, Novartis, Biogen: travel grants
Williams, M. J.
Biogen Idec: Consulting Fee and Speakers Bureau
Novartis: Consulting Fee , Contracted research and Speakers Bureau
Teva Neuroscience: Consulting Fee and Speakers Bureau
Mallingckrodt: Consulting Fee and Speakers Bureau
Sanofi Genzyme: Consulting Fee and Speakers Bureau
Genentech: Consulting Fee and Speakers Bureau
Williamson, E.
Teva Neuroscience, Inc.: Consulting Fee
Novartis Pharmaceuticals Corporation: Consulting Fee
Merck & Co., Inc.: Consulting Fee
Biogen Inc.: Consulting Fee
EMD Serono Inc.: Consulting Fee
Celgene Corporation: Consulting Fee
Sanofi S.A.: Consulting Fee
Alexion Pharmaceuticals Inc.: Contracted research
Winthrop, K.
Pfizer, BMS: Contracted research
Pfizer, BMS, Roche, UCB, Lilly, Abbvie: Consulting Fee
Wolinsky, J. S.
AbbVie, Alkermes, Biogen, Clene Nanomedicine, Forward Pharma, MedDay, Novartis, Roche Genentech, Sanofi Genzyme: Consulting Fee
received royalties for monoclonal antibodies out-licenced to Chemicon International through UTHealth: Royalty
Alkermes: Consulting Fee
Biogen: Consulting Fee
Bionest: Consulting Fee
Celgene: Consulting Fee
Clene Nanomedicine: Consulting Fee
EMD Serono: Consulting Fee
Forward Pharma A/S: Consulting Fee
MedDay Pharmaceuticals: Consulting Fee
Novartis Pharmaceuticals: Consulting Fee
Otsuka: Consulting Fee
PTC Therapeutics: Consulting Fee
Roche Genentech: Consulting Fee
Sanofi Genzyme: Consulting Fee
Strategic Consultants International: Consulting Fee
rec'd through UTHealth from Millipore Corporation: Royalty
AbbVie, Alkermes, Biogen, Bionest, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche, Sanofi Genzyme: Consulting Fee
monoclonal antibodies out-licensed to Chemicon International through UTHealth: Royalty
For monoclonal antibodies out-licenced to Chemicon International through UTHealth: Royalty
Wolinsky, J. S.
for monoclonal antibodies out-licensed to Chemicon International through UTHealth: Royalty
AbbVie, Alkermes, Biogen, Bionest, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche, Sanofi Genzyme: Consulting Fee
Wong, K. H.
Biogen: research support
Wormser, D.
F. Hoffmann-La Roche Ltd: Employee of , Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary
F. Hoffmann-La Roche Ltd: Employee of and Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Wray, S.
Alkermes, Bayer, Biogen, EMD Serono, Genentech/Roche, Novartis, Sanofi, and Teva: Consultant, principal investigator, and/or speaker fees
Paid consultant, speaker, and/or contract researcher for Acorda, Bayer, Biogen, EMD Serono, Genzyme, Novartis, Questcor, Receptos, Genentech/Roche, and Teva: Consulting Fee , Contracted research and Speakers Bureau
Wundes, A.
Biogen, Alkermes: Contracted research
Wundes, A.
Alkermes: Contracted research

Y

Yun, J.
Employee and stockholder of Biogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds) and Salary

Z

Zamvil, S.
Biogen: Consulting Fee
Zarif, M.
Acorda, Biogen, Genzyme and Teva: Speaker fees
Zheng, H.
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech, Inc.: Salary
Zhovtis-Ryerson, L.
Personal compensation for speaker and advisory board activities from Biogen, Teva: Speakers Bureau
Biogen: Research Support
Ziehn, M.
Novartis Pharmaceuticals Corporation: Salary
Ziemssen, T.
Biogen, Novartis, Sanofi, and Teva: Grant/research support
Almirall, Bayer Biogen, Merck, Novartis, Roche, Sanofi, and Teva: Consulting and/or speaking fees
Zivadinov, R.
Teva Pharmaceuticals, Biogen Idec, EMD Serono, Sanofi Genzyme, Claret Medial, IMS Health, Novartis: Consulting Fee and Speakers Bureau
Teva Pharmaceuticals, Sanofi Genzyme, Novartis, Claret Medical, Intekrin-Coherus, IMS Health: Contracted research

A B C D E F G H I J K L M N O P R S T V W Y Z